骨转移放疗分割趋势:当代全国性分析
该研究利用美国国家癌症数据库(NCDB)分析了2010至2015年间乳腺癌、前列腺癌和非小细胞肺癌骨转移患者的放疗分割模式。结果显示,单次8 Gy治疗从3%增至7%,超过30 Gy/10次的长疗程从34%降至15%,但30 Gy/10次仍是最常用方案(50%-60%)。单次分割的预测因素包括高龄、未接受全身治疗、距离治疗中心更远、学术中心治疗、非脊柱/非颅骨转移及较晚治疗年份。
要点
- 骨转移单次8 Gy放疗从2010年3%升至2015年7%,但仍不足10%。
- 超过30 Gy/10次的长疗程从34%降至15%,30 Gy/10次仍最常用(50%-60%)。
- 单次分割预测因素:高龄、无全身治疗、远距离、学术中心、非脊柱/颅骨转移、较晚年份。
核心结论
- 骨转移单次分割放疗使用率稳步上升但仍低于10%,长疗程方案显著减少,30 Gy/10次仍是最常用方案。
研究设计与样本
- 基于美国国家癌症数据库(NCDB)的回顾性队列研究,纳入2010至2015年诊断时即有骨转移并接受骨定向放疗的乳腺癌、前列腺癌和非小细胞肺癌患者,共17,859例。
主要发现
- 患者中位年龄67岁,67%为前列腺癌原发,62%接受脊柱治疗。
- 单次分割治疗从2010年3%增至2015年7%,超过30 Gy/10次的长疗程从34%降至15%。
- 最常用方案仍为30 Gy/10次,占50%-60%的病例。
- 单次分割的预测因素包括高龄、未接受全身治疗、距离治疗中心更远、学术中心治疗、非脊柱/非颅骨转移及较晚治疗年份。
关键数值与推荐
- 美国放射肿瘤学会(ASTRO)指南基于随机数据推荐使用较少分次的方案。
- 本研究定义的方案包括:8 Gy/1次、20-24 Gy/5-6次、30 Gy/10次、>30 Gy/10次。
临床怎么用
- 尽管指南推荐少分次,但单次分割在骨转移 palliative 放疗中应用仍不足10%,30 Gy/10次仍是主流,提示需加强指南落实。
- 识别单次分割预测因素(如高龄、无全身治疗、远距离、学术中心等)有助于针对性推广短疗程。
局限性
- 研究为回顾性数据库分析,可能存在未测量混杂因素。
- 仅纳入乳腺癌、前列腺癌和非小细胞肺癌患者,结论外推需谨慎。
- 未报告具体剂量分布、症状缓解及生存结局等数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Radiation therapy remains an important palliative tool for patients with bone metastases. The guidelines from the American Society for Therapeutic Radiation Oncology recommend the use of fewer fractions based on randomized data. We used the National Cancer Database to examine trends in radiation fractionation for patients with bone metastases. METHODS AND MATERIALS: We queried breast, prostate, and non-small cell lung cancer in the National Cancer Database from 2010 to 2015 for patients with bone metastases at the time of diagnosis who received bone-directed radiation therapy of 8 Gy in 1 fraction, 20 Gy to 24 Gy in 5 to 6 fractions, 30 Gy in 10 fractions, or >30 Gy in 10 fractions. We tabulated the baseline characteristics, and a multivariable logistic regression analysis was used to identify predictors of single-fraction treatment. RESULTS: We identified 17,859 patients who met the study criteria. The median patient age was 67 years, and the majority of patients (67%) had primary prostate cancer. Most patients (62%) received spine treatment. Single-fraction treatment increased over time from 3% in 2010 to 7% by 2015. Use of more protracted courses (>30 Gy in 10 fractions) decreased from 34% to 15% over the same interval. The most commonly used regimen (50%-60% of cases) remained 30 Gy in 10 fractions. Predictors of single-fraction treatment included increased age, no systemic therapy, increasing distance from facility, treatment at an academic center, nonspine/nonskull metastasis, and more recent treatment year. CONCLUSIONS: Use of single-fraction radiation for bone metastases has increased steadily but still accounts for <10% of palliative courses. The use of more protracted regimens has decreased significantly, although 30 Gy in 10 fractions remains the most widely used regiment.
引用
- Wegner RE, Matani H, Colonias A, et al. Trends in Radiation Fractionation for Bone Metastases: A Contemporary Nationwide Analysis. Pract Radiat Oncol. 2020. PMID: 32289552. doi:10.1016/j.prro.2020.03.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。